Filing Details

Accession Number:
0001486189-23-000027
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-08 12:18:53
Reporting Period:
2023-08-25
Accepted Time:
2023-09-08 12:18:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1870144 Cardio Diagnostics Holdings Inc. CDIO In Vitro & In Vivo Diagnostic Substances (2835) 870925574
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1950789 Meeshanthini Dogan 311 W Superior St, Ste 444
Chicago IL 60654
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-25 1,770 $0.56 111,864 No 4 P Indirect See note(3)
Common Stock Acquisiton 2023-08-31 16,481 $0.55 128,345 No 4 P Indirect See note(3)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See note(3)
No 4 P Indirect See note(3)
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
  3. These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein.